Literature DB >> 4918202

Further experience with the kinetic method for the study of drugs against Mycobacterium leprae in mice. Activities of DDS, DFD, ethionamide, capreomycin and PAM 1392.

C C Shepard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4918202

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN： 0148-916X


× No keyword cloud information.
  11 in total

1.  Using bioluminescence to monitor treatment response in real time in mice with Mycobacterium ulcerans infection.

Authors:  Tianyu Zhang; Si-Yang Li; Paul J Converse; Deepak V Almeida; Jacques H Grosset; Eric L Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  Detection of live and antibiotic-killed bacteria by quantitative real-time PCR of specific fragments of rRNA.

Authors:  Steve Aellen; Yok-Ai Que; Bertrand Guignard; Marisa Haenni; Philippe Moreillon
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

3.  Activity of derivatives and analogs of dapsone against Mycobacterium leprae.

Authors:  L Levy
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

4.  Immunity to Mycobacterium leprae infections in mice stimulated by M. leprae, BCG, and graft-versus-host reactions.

Authors:  C C Shepard; R Van Landingham; L L Walker
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

5.  Mycobacterium leprae is naturally resistant to PA-824.

Authors:  Ujjini H Manjunatha; Ramanuj Lahiri; Baljit Randhawa; Cynthia S Dowd; James L Krahenbuhl; Clifton E Barry
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

6.  Multidrug resistant Mycobacterium leprae from patients with leprosy.

Authors:  S Maeda; M Matsuoka; N Nakata; M Kai; Y Maeda; K Hashimoto; H Kimura; K Kobayashi; Y Kashiwabara
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

7.  Effect of levamisole on Mycobacterium leprae in mice.

Authors:  C C Shepard; R Van Landingham; L L Walker
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

8.  Susceptibility of Mycobacterium leprae to dapsone as a determinant of patient response to acedapsone.

Authors:  L Levy; J H Peters
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

9.  Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in mice.

Authors:  Deepak Almeida; Paul J Converse; Zahoor Ahmad; Kelly E Dooley; Eric L Nuermberger; Jacques H Grosset
Journal:  PLoS Negl Trop Dis       Date:  2011-01-04

10.  Bactericidal activity does not predict sterilizing activity: the case of rifapentine in the murine model of Mycobacterium ulcerans disease.

Authors:  Deepak V Almeida; Paul J Converse; Si-Yang Li; Sandeep Tyagi; Eric L Nuermberger; Jacques H Grosset
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.